|
Apoptosis
Citations 351-360 of 746 total displayed.
|
Past content
(since May 2000):
|
Farnesyltransferase inhibitor tipifarnib is well tolerated, induces stabilization of disease, and inhibits farnesylation and oncogenic/tumor survival pathways in patients with advanced multiple myeloma
- Melissa Alsina, Rafael Fonseca, Edward F. Wilson, A. Nelida Belle, Elvira Gerbino, Tammy Price-Troska, Rose M. Overton, Gregory Ahmann, Laura M. Bruzek, Alex A. Adjei, Scott H. Kaufmann, John J. Wright, Daniel Sullivan, Benjamin Djulbegovic, Alan B. Cantor, Philip R. Greipp, William S. Dalton, and Saïd M. Sebti
Blood 2004; 103: 3271-3277.
[Abstract]
[Full text]
[PDF]
G-CSF-induced tyrosine phosphorylation of Gab2 is Lyn kinase dependent and associated with enhanced Akt and differentiative, not proliferative, responses
- Quan-Sheng Zhu, Lisa J. Robinson, Vera Roginskaya, and Seth J. Corey
Blood 2004; 103: 3305-3312.
[Abstract]
[Full text]
[PDF]
Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells
- Göran Carlsson, Andrew A. G. Aprikyan, Ramin Tehranchi, David C. Dale, Anna Porwit, Eva Hellström-Lindberg, Jan Palmblad, Jan-Inge Henter, and Bengt Fadeel
Blood 2004; 103: 3355-3361.
[Abstract]
[Full text]
[PDF]
Defective fetal liver erythropoiesis and T lymphopoiesis in mice lacking the phosphatidylserine receptor
- Yuya Kunisaki, Sadahiko Masuko, Mayuko Noda, Ayumi Inayoshi, Terukazu Sanui, Mine Harada, Takehiko Sasazuki, and Yoshinori Fukui
Blood 2004; 103: 3362-3364.
[Abstract]
[Full text]
[PDF]
Kaposi sarcoma-associated herpesvirus (KSHV) induces heme oxygenase-1 expression and activity in KSHV-infected endothelial cells
- Shane C. McAllister, Scott G. Hansen, Rebecca A. Ruhl, Camilo M. Raggo, Victor R. DeFilippis, Deborah Greenspan, Klaus Früh, and Ashlee V. Moses
Blood 2004; 103: 3465-3473.
[Abstract]
[Full text]
[PDF]
Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2
- Andreas Burchert, Dali Cai, Lorenz C. Hofbauer, Magnus K. R. Samuelsson, Emily P. Slater, Justus Duyster, Markus Ritter, Andreas Hochhaus, Rolf Müller, Martin Eilers, Manuel Schmidt, and Andreas Neubauer
Blood 2004; 103: 3480-3489.
[Abstract]
[Full text]
[PDF]
JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells
- Kelly Davison, Koren K. Mann, Samuel Waxman, and Wilson H. Miller, Jr
Blood 2004; 103: 3496-3502.
[Abstract]
[Full text]
[PDF]
Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines
- Yulia Nefedova, Pingyan Cheng, Melissa Alsina, William S. Dalton, and Dmitry I. Gabrilovich
Blood 2004; 103: 3503-3510.
[Abstract]
[Full text]
[PDF]
Fenretinide enhances rituximab-induced cytotoxicity against B-cell lymphoma xenografts through a caspase-dependent mechanism
- Ajay K. Gopal, John M. Pagel, Nathan Hedin, and Oliver W. Press
Blood 2004; 103: 3516-3520.
[Abstract]
[Full text]
[PDF]
Inhibition of fibroblast growth factor receptor 3 induces differentiation and apoptosis in t(4;14) myeloma
- Suzanne Trudel, Scott Ely, Yildiz Farooqi, Maurizio Affer, Davide F. Robbiani, Marta Chesi, and P. Leif Bergsagel
Blood 2004; 103: 3521-3528.
[Abstract]
[Full text]
[PDF]
|
|
